# Farmers & Merchants Bancshares, Inc.: overview FMFG · OTC · CIK 1698022 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fmfg.md) · [Financials](/companies/fmfg/financials.md) · [Filings](/companies/fmfg/filings.md) · [Insiders](/companies/fmfg/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.36](/filings/0001437749-25-035228.md) | not reported | [0.37](/filings/0001437749-26-017230.md) | [0.38](/filings/0001437749-26-027027.md) | [0.53](/filings/0001437749-25-035228.md) | not reported | [0.56](/filings/0001437749-26-017230.md) | [0.58](/filings/0001437749-26-027027.md) | | Free cash flow | $k | [374 d](/filings/0001437749-25-035228.md) | [(201) d](/filings/0001437749-26-009952.md) | [484](/filings/0001437749-26-017230.md) | [1,207 d](/filings/0001437749-26-027027.md) | [2,737 d](/filings/0001437749-25-035228.md) | [1,252 d](/filings/0001437749-26-009952.md) | [1,910](/filings/0001437749-26-017230.md) | [1,501 d](/filings/0001437749-26-027027.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.70](/filings/0001437749-22-005951.md) | [2.66](/filings/0001437749-24-007276.md) | [2.08](/filings/0001437749-25-007333.md) | [1.37](/filings/0001437749-26-009952.md) | [1.81](/filings/0001437749-26-009952.md) | | Free cash flow | $m | [11.4](/filings/0001437749-23-006153.md) | [6.7](/filings/0001437749-24-007276.md) | [5.0](/filings/0001437749-25-007333.md) | [1.0](/filings/0001437749-26-009952.md) | [5.7](/filings/0001437749-26-009952.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fmfg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Siena Capital Partners GP, LLC](/funds/1694886.md) | 2026-06-30 | $1.2m | 68,906 | | Unchanged | ## Recent filings [All 289 filings](/companies/fmfg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 13:00 ET | [8-K](/filings/0001437749-26-033188.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-033188 | | 2026-09-23 | 20:15 ET | [8-K](/filings/0001437749-26-031063.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-031063 | | 2026-08-11 | 20:31 ET | [10-Q](/filings/0001437749-26-027027.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027027 | | 2026-07-23 | 13:01 ET | [8-K](/filings/0001437749-26-024236.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-024236 | | 2026-06-16 | 20:34 ET | [8-K](/filings/0001437749-26-020810.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001437749-26-020810 | | 2026-05-21 | 20:19 ET | [8-K](/filings/0001437749-26-018092.md) | 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001437749-26-018092 | | 2026-05-19 | 20:46 ET | [8-K](/filings/0001437749-26-017800.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-017800 | | 2026-05-15 | 13:01 ET | [10-Q](/filings/0001437749-26-017230.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017230 | | 2026-04-30 | 20:31 ET | [8-K](/filings/0001437749-26-014235.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-014235 | | 2026-04-29 | 20:31 ET | [8-K](/filings/0001437749-26-013896.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-013896 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-009952.md), filed Mar 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1698022 - Tickers: FMFG - Exchange: OTC - SIC code: 6036 Savings Institutions, Not Federally Chartered - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.